Alnylam Pharmaceuticals Aktie
276,10
EUR
-7,40
EUR
-2,61
%
318,69
USD
-9,90
USD
-3,01
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
| 20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
| 03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung